Search Results

You are looking at 1 - 8 of 8 items for :

  • "convalescent plasma" x
Clear All
Orvosi Hetilap
Authors: Ilona Bobek, László Gopcsa, Marienn Réti, Gabriella Bekő, Lilla Hancz, Botond Lakatos, Eszter Molnár, Sándor Nagy, Péter Reményi, Gabriella Sebestyén, János Sinkó, János Szlávik, Miklós Szolnoky and István Vályi-Nagy

] 5 Mair-Jenkins J, Saavedra-Campos M, Baillie JK, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of

Open access
Hematológia–Transzfuziológia
Authors: Attila Tordai, Sándor Nagy, Klára Baróti-Tóth, Imelda Marton, Mária Lázár, Judit Demeter, Tamás Masszi and Andrea Matusovits

. 8 Franchini M, Marano G, Velati C, et al. Operational protocol for donation of anti-COVID-19 convalescent plasma in Italy. Vox Sang. 2020 Apr 23

Open access

prevent disease but not as a permanent tool to treat disease. Convalescent plasma therapy is only effective when administered in early stage of disease as sudden after onset of symptoms. Although studies showed that in case of COVID-19 it has been

Restricted access

–1548. 28 U. S. Food and Drug Administration. Investigational COVID- 19 Convalescent Plasma – Emergency INDs. FDA, White Oak, MD. Available from: https

Open access

] 16 Bobek I, Gopcsa L, Réti M. et al. Successful administration of convalescent plasma in critically ill COVID-19 patients in Hungary: the first two cases. [Az első két sikeres, convalescens

Restricted access

.gov. Available from: https://www.Clinicaltrials.gov [accessed: April 19, 2020]. 18 Brank D. FDA OKs emergency use of convalescent plasma for seriously

Open access
Hematológia–Transzfuziológia
Authors: Bálint Gergely Szabó, Ilona Bobek, Marienn Réti, László Gopcsa, Dóra Mathiász, Botond Lakatos, Gabriella Bekő, Mónika Pető, János Sinkó, Gábor Mikala, Zoltán Kis, János Szlávik, Péter Reményi and István Vályi-Nagy

] 52 Duan K, Liu B, Li C, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020; 117(17): 9490

Open access

from passive immunization. The plasma of patients who have recovered from COVID-19 contains IgM and IgG immunoglobulins generated against SARS-CoV-2 antigens. These antibodies can be collected as convalescent plasma and transferred by an intravenous

Open access